Pulmonx Corporation reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 19.28 million compared to USD 15.43 million a year ago. Net loss was USD 13.89 million compared to USD 14.28 million a year ago. Basic loss per share from continuing operations was USD 0.36 compared to USD 0.38 a year ago.
For the full year, sales was USD 68.68 million compared to USD 53.66 million a year ago. Net loss was USD 60.84 million compared to USD 58.92 million a year ago. Basic loss per share from continuing operations was USD 1.6 compared to USD 1.59 a year ago.